4Piotr W, Marek S, Zbigniew N, et al. Insulin resistance as a noveltherapeutic target in patients with chronic kidney disease treated with dialysis. Pol Arch Med Wewn,2010,120:54-57.
5Kobayashi S, Maesato K, Moriya I-I, et aI. Insulin resistance in patients with chronic kidney disease. Am J Kidney Dis,2005,45:275-280.
6Kobayashi S,Maejuma S,Ikeda T,et al. Impact of dialysis therapy on insulin resistance in end-stage renal disease : comparison of haemodial- ysis and continuous ambulatory peritoneal dialysis. Nephrol Dial Transpl,2000,15 : 65 -70.
7Wallace TM, Levy JC, Matthews DR. Use and abuse of HOMA model- ing. Diabetes Care ,2004,27 : 1487-1495.
8/danley AJG, Williams K, Stern MP, et al. Homeostasis model assess- ment of insulin resistance in relation to the incidence of cardiovascular disease--The San Antonio Heart Study. Diabetes Care ,2002,25:1177- 1184.
9Ikee R, Hamasaki Y, Oka M, et al. Glucose metabolism, insulin resist- ance,and renal pathology in non-diabetic chronic kidney disease. Nephron Clin Pract ,2008,108 : C163-C168.
10Sarafidis PA, Ruilope LM. Insulin resistance, hyperinsulinemia, and renal injury: mechanisms and implications. Am J Nephrol, 2006,26 : 232 -244.
